Molecular Pharmacology (USA), Ltd.
Molecular Pharmacology (USA), Ltd. (MLPH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MLPH · as of Jun 8, 2026
Key Statistics
Explore Molecular Pharmacology (USA), Ltd. Data
mlph stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
mlph competitorsMLPH
ACBM
AFFY
AMBS
BSSP
ITMCStock Performance
Full HistoryAbout Molecular Pharmacology (USA), Ltd.
Molecular Pharmacology (USA), Ltd. As a development-stage company, Molecular Pharmacology (USA) Limited (MLPH) is dedicated to the creation and market introduction of solutions for pain and inflammation, with a primary focus on the Aus…
what is molecular pharmacology (usa), ltd. · mlph stock overview · molecular pharmacology (usa), ltd. company profile · who is molecular pharmacology (usa), ltd. ceo · mlph OTC · molecular pharmacology (usa), ltd. headquarters · molecular pharmacology (usa), ltd. business segments
About Stock Overview & Key Data
Molecular Pharmacology (USA), Ltd. (MLPH) is a Healthcare company in the Biotechnology industry, listed on OTC since Jul 24, 2009. As of the latest trading session, MLPH stock price is $0.00, with a market capitalization of $111,554. The stock has returned +150.00% over the past 12 months and +150.00% year-to-date.
In fiscal year 2024, Molecular Pharmacology (USA), Ltd. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Molecular Pharmacology (USA), Ltd. (MLPH) stock price is $0.00. The stock is traded on OTC under the ticker symbol MLPH. The 52-week range is $0.00 – $0.01.